ArticleArthritis research & therapy2026
Deficiency of Krüppel-like factor 15 activates β-catenin and is involved in the development of osteoarthritis : Author.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Krüppel-like factor 15 is a metabolism-related transcription factor that has been implicated in the regulation of the Wnt/β-catenin signaling pathway. This study aimed to elucidate its function in cartilage, particularly its interaction with β-catenin, using inducible cartilage-specific knockout mice. Krüppel-like factor 15 knockout mice and control mice underwent destabilization of medial meniscal surgery to induce osteoarthritis. Histological analysis and immunohistochemistry were carried out, along with in vitro co-immunoprecipitation, double immunofluorescence, and subcellular fractionation, and a dual-luciferase reporter assay. The effects of Wnt3A stimulation and treatment with Wnt/β-catenin inhibitors were evaluated. Knockout mice showed significantly more cartilage degeneration at eight weeks after surgery when compared with control mice. Knockout mice also showed elevated Osteoarthritis Research Society International scores and increased expression of β-catenin, matrix metalloprotease-13, and a disintegrin-like metalloprotease with thrombospondin motifs-5, along with decreased expression of SRY-box transcription factor 9. Krüppel-like factor 15 was seen to physically interact and colocalize with β-catenin in chondrocyte nuclei. Its deficiency promoted canonical Wnt/β-catenin pathway activation and nuclear β-catenin accumulation. Consistently, dual-luciferase reporter assays demonstrated increased β-catenin/TCF transcriptional activity in Krüppel-like factor 15-deficient chondrocytes, which was further enhanced by Wnt3A stimulation. Wnt3A stimulation amplified catabolic gene expression and suppressed anabolic factor expression. However, administration of a Wnt/β-catenin signaling inhibitor canceled out these effects. This study indicates that Krüppel-like factor 15 interacts with β-catenin and functions as a negative regulator of Wnt/β-catenin signaling in cartilage, maintaining matrix homeostasis, and suppressing osteoarthritis progression. Deficiency of Krüppel-like factor 15 promotes catabolism and inhibits anabolism mediated by β-catenin in cartilage. These findings suggest that Krüppel-like factor 15 may be a potential therapeutic target for osteoarthritis, either by restoring its function or enhancing its interaction with β-catenin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.